Erratum to the effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension
Erratum

Erratum to the effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension

Zheyong Huang1#, Jiatian Cao1#, Yumeng Yao2, Xuejuan Jin1, Zhe Luo3, Yuan Xue3, Chouwen Zhu4, Yanan Song1, Ying Wang1, Yunzeng Zou1, Juying Qian1, Kaihuan Yu5, Hui Gong1, Junbo Ge1

1Shanghai Institute of Cardiovascular Diseases, 2Department of Infection Disease, 3Department of Critical Medicine, 4Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai, China; 5Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, China

#These authors contributed equally to this work.

Correspondence to: Hui Gong, PhD and Junbo Ge, MD, PhD. Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 180 Feng Lin Road, Shanghai 200032, China. Email: gonghui2005@fudan.edu.cn; junboge@126.com.

doi: 10.21037/atm-2020-27


Erratum to: Ann Transl Med 2020;8:430


The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension

In the article entitled “The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension (1), there are some errors. In Table 2, the data about in hospital mortality should be deleted, because the correct data about in hospital mortality have been showed in Table 6. The Table 2 should be replaced by the following table.

Table 2
Table 2 Comparison of demographic and clinical characteristics of patients with COVID-19 between Group A (including RAS blockers treatment) and Group B (non-RAS blockers treatment)
Full table

We regret the errors.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Huang Z, Cao J, Yao Y, et al. The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension. Ann Transl Med 2020;8:430. [Crossref] [PubMed]
Cite this article as: Huang Z, Cao J, Yao Y, Jin X, Luo Z, Xue Y, Zhu C, Song Y, Wang Y, Zou Y, Qian J, Yu K, Gong H, Ge J. Erratum to the effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension. Ann Transl Med 2020;8(17):1119. doi: 10.21037/atm-2020-27